ADC抗體內(nèi)吞檢測(cè)試劑
應(yīng)用(Application)
Antibody Internalization Detection Reagent (Cat. No. IGG-PZF2001) is formed by conjugating anti-human Fc antibody with a pH-sensitive red fluorescent dye. It can be used to assess the endocytosis of antibodies by labeling the human IgG Fc region. After co-incubation with the target antibody, a stable fluorescent complex can be formed to detect the endocytosis of the antibody in the cells. Furthermore, with the pH-sensitive dye, not only can it significantly enhance the fluorescence signal in an acidic environment, but also prevent the background noise.
特異性(Specificity)
Specifically recognizes the human antibody Fc portion.
檢測(cè)波長(zhǎng)(Detection Wavelength)
Excitation Wavelength: 643 nm
Emission Wavelength: 660 nm
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please protect from light and avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 24 months in lyophilized state;
-20°C to -70°C for 12 months after reconstitution.

關(guān)鍵字: ADC抗體內(nèi)吞檢測(cè)試劑;內(nèi)吞檢測(cè)試劑;ADC內(nèi)吞檢測(cè)試劑;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。